Successes and failures of current treatment of heart failure

Cleland, John GF; Swedberg, Karl; Poole-Wilson, Philip A

doi:10.1016/s0140-6736(98)90015-0

Cited by 142Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular and exercise physiology

Successes and failures of current treatment of heart failure

Cleland, John GF, Swedberg, Karl, Poole-Wilson, Philip A·1998·The Lancet

DOI 10.1016/s0140-6736(98)90015-0

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(98)90015-0

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

In CHF, cough is commonly either due to pulmonary congestion or secondary to angiotensin-converting enzyme inhibitors through an accumulation of bradykinin and prostaglandins.
“In CHF, cough is commonly either due to pulmonary congestion or secondary to angiotensin‐converting enzyme inhibitors through an accumulation of bradykinin and prostaglandins. 62”
From Prioritizing symptom management in the treatment of chronic heart failure (2020) · cites this paper as [62]

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029 · see citing works
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911 · see citing works
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649 · see citing works
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165 · see citing works
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
Swedberg, K. B., & KJEKSHUS, J. K. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762 · see citing works
Self-citation
Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725 · see citing works
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205 · see citing works
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016 · see citing works
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833 · see citing works
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400 · see citing works
Survival after the onset of congestive heart failure in Framingham Heart Study subjects.
Ho, K. K. L., Anderson, K. M., Kannel, W. B., Grossman, W., & Levy, D. A. (1993) · Circulation · doi:10.1161/01.cir.88.1.107 · Cited by 1,865 · see citing works
Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
Julian, D. G., Moss, A. J., Murray, G. D., Poole-Wilson, P. A., Simoons, M. L., Ball, S., Bender, N., Cleland, J. G. F., Dl, C., Pj, C., et al. (1993) · The Lancet · Cited by 1,860 · see citing works
Self-citation
A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
Køber, L., Torp-Pedersen, C. T., Carlsen, J. E., Bagger, H., Eliasen, P., Lyngborg, K., Videbæk, J., Cole, D. S., Auclert, L., Pauly, N., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332503 · Cited by 1,768 · see citing works
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
Pitt, B., Segal, R., Martínez, F. A., Meurers, G., Cowley, A. J., Thomas, I., DEEDWANIA, P. C., Ney, D. E., Snavely, D. B., & Chang, P. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01187-2 · Cited by 1,656 · see citing works
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
Bristow, M. R., Gilbert, E. M., Abraham, W. T., Adams, K. F., Fowler, M. B., Hershberger, R. E., Kubo, S. H., Narahara, K. A., Ingersoll, H., Krueger, S., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2807 · Cited by 1,303 · see citing works
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
Waagstein, F., Hjalmarson, Å. C., Swedberg, K. B., Bristow, M. R., Gilbert, E. M., Camerini, F., Fowler, M. B., Silver, M. A., Johnson, M. R., & Goss, F. (1993) · The Lancet · doi:10.1016/0140-6736(93)92930-r · Cited by 1,234 · see citing works
Self-citation
Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure
Packer, M., O’Connor, C. M., Ghali, J. K., Pressler, M. L., Carson, P. E., Belkin, R. N., Miller, A. B., Neuberg, G. W., Frid, D. J., WERTHEIMER, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610103351504 · Cited by 1,194 · see citing works
A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
(1994) · Circulation · doi:10.1161/01.cir.90.4.1765 · Cited by 1,056 · see citing works
Prophylactic Use of Implanted Cardiac Defibrillators in Patients at High Risk for Ventricular Arrhythmias after Coronary-Artery Bypass Graft Surgery
Bigger, J. T. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372201 · Cited by 1,007 · see citing works
Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective
Vasan, R. S., Benjamin, E. J., & Levy, D. A. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00381-9 · Cited by 889 · see citing works
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.
Waagstein, F., Hjalmarson, Å. C., Varnauskas, E., & Wallentin, I. (1975) · Heart · doi:10.1136/hrt.37.10.1022 · Cited by 829 · see citing works
Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors
Packer, M., Gheorghiade, M., Young, J. B., Costantini, P. J., Adams, K. F., Cody, R. J., Smith, L. K., Voorhees, L. V., Gourley, L. A., & Jolly, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307013290101 · Cited by 826 · see citing works
Readmission After Hospitalization for Congestive Heart Failure Among Medicare Beneficiaries
Krumholz, H. M. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440220103013 · Cited by 821 · see citing works
Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors
O'Mara, N. B., & Zimmerman, W. B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312093292417 · Cited by 639 · see citing works
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
Colucci, W. S., Packer, M., Bristow, M. R., Gilbert, E. M., Cohn, J. N., Fowler, M. B., Krueger, S. K., Hershberger, R. E., Uretsky, B. F., Bowers, J. A., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2800 · Cited by 635 · see citing works
Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
McDonagh, T. A., Morrison, C., Lawrence, A., Ford, I., Tunstall-Pedoe, H., McMurray, J. J. V., & Dargie, H. J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03033-x · Cited by 631 · see citing works
Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure
Packer, M., Colucci, W. S., Sackner‐Bernstein, J., Liang, C., Goldscher, D. A., Freeman, I., Kukin, M. L., Kinhal, V., Udelson, J. E., Klapholz, M., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2793 · Cited by 613 · see citing works
Ventricular Dysfunction and the Risk of Stroke after Myocardial Infarction
Loh, E., Sutton, M. S. J., Wun, C., Rouleau, J. L., Flaker, G. C., Gottlieb, S. S., Lamas, G. A., Moyé, L. A., Goldhaber, S. Z., & Pfeffer, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360403 · Cited by 602 · see citing works
Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
Australia/New Zealand Heart Failure Research Collaborative Group (1997) · The Lancet · doi:10.1016/s0140-6736(97)80008-6 · Cited by 588 · see citing works
Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial
Uretsky, B. F., Young, J. B., Shahidi, F. E., Yellen, L., Harrison, M., & Jolly, M. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90403-n · Cited by 580 · see citing works
DOUBLE-BLIND COMPARISON OF CAPTOPRIL ALONE AGAINST FRUSEMIDE PLUS AMILORIDE IN MILD HEART FAILURE
Richardson, A., Scriven, A., Poole-Wilson, P. A., Bayliss, J., Parameshwar, J. K., & Sutton, G. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91074-9 · Cited by 432 · see citing works
Self-citation
Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute Workshop)
Manolio, T. A., Baughman, K. L., Rodeheffer, R. R., Pearson, T. A., Bristow, J. D., Michels, V. V., Abelmann, W. H., & Harlan, W. R. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90901-a · Cited by 432 · see citing works
PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE
Swedberg, K. B., Hjalmarson, Å. C., Waagstein, F., & Wallentin, I. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92010-5 · Cited by 418 · see citing works
Self-citation
Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.
Chadda, K., Goldstein, S., Byington, R. P., & Curb, J. D. (1986) · Circulation · doi:10.1161/01.cir.73.3.503 · Cited by 402 · see citing works
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
Kjekshus, J., Pedersen, T. R., Olsson, A. G., Færgeman, O., & Pyörälä, K. (1997) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(97)90022-1 · Cited by 386 · see citing works
Effect of Beta-Blockade on Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Clinical Trials
Heidenreich, P. A., Lee, T. T., & Massie, B. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00104-6 · Cited by 357 · see citing works
Effect of the Calcium Antagonist Felodipine as Supplementary Vasodilator Therapy in Patients With Chronic Heart Failure Treated With Enalapril
Cohn, J. N., Ziesche, S., Smith, R. F., Anand, I. S., Dunkman, W. B., Loeb, H. S., Cintron, G. B., Boden, W. E., Baruch, L., Rochin, P., et al. (1997) · Circulation · doi:10.1161/01.cir.96.3.856 · Cited by 357 · see citing works
Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance
Setaro, J. F., Zaret, B. L., Schulman, D. S., Black, H. R., & Soufer, R. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90937-v · Cited by 349 · see citing works
Trends in hospitalization for heart failure in Scotland 1980-1990
McMurray, J. J. V., McDonagh, T., Morrison, C. E., & Dargie, H. J. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.9.1158 · Cited by 347 · see citing works
Ejection Fraction and Risk of Thromboembolic Events in Patients With Systolic Dysfunction and Sinus Rhythm: Evidence for Gender Differences in the Studies of Left Ventricular Dysfunction Trials
Dries, D. L., Rosenberg, Y., Waclawiw, M. A., & DOMANSKI, M. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00019-3 · Cited by 295 · see citing works
The treatment of heart failure
Remme, W. J., Cleland, J. G. F., Dargie, H. J., Erdmann, E., Ferrari, R., Kjekshus, J., Michel Komajda, N., Poole-Wilson, P. A., Riegger, G. A. J., Soler‐Soler, J., et al. (1997) · European Heart Journal · Cited by 293 · see citing works
Self-citation
Losartan in Heart Failure
Crozier, I., Ikram, H., Awan, N. A., Cleland, J. G. F., Stephen, N., Dickstein, K., Frey, M., Young, J. B., Klinger, G. H., Makris, L., et al. (1995) · Circulation · doi:10.1161/01.cir.91.3.691 · Cited by 291 · see citing works
Self-citation
The Registry of the International Society for Heart and Lung Transplantation: fourteenth official report--1997.
Hosenpud, J. D., Bennett, L. E., Keck, B. M., Fiol, B., & Novick, R. J. (1997) · PubMed · Cited by 284 · see citing works
Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
Masaki, H., Kurihara, T., Yamaki, A., Inomata, N., Nozawa, Y., Mori, Y., Murasawa, S., Kizima, K., Maruyama, K., Horiuchi, M., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1885 · Cited by 260 · see citing works
EFFECT OF PROPRANOLOL IN MYOCARDIAL INFARCTION
Snow, P. J. D. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90863-9 · Cited by 247 · see citing works
Guidelines for the diagnosis of heart failure
THE TASK FORCE ON HEART FAILURE OF THE EUROPEAN SOCIETY OF CARDIOLOGY (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060992 · Cited by 233 · see citing works
Effects of beta-blocker therapy on mortality in patients with heart failure: A systematic overview of randomized controlled trials
Doughty, R. N., Rodgers, A., Sharpe, N., & MacMahon, S. W. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015297 · Cited by 230 · see citing works
Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance
(1998) · European Heart Journal · doi:10.1053/euhj.1997.0736 · Cited by 208 · see citing works
Mode of death in chronic heart failure: A request and proposition for more accurate classification
Narang, R., Cleland, J. G. F., Erhardt, L., Ball, S., Coats, A. J. S., Cowley, A., Dargie, H. J., Hall, A. S., Hampton, J. R., & Poole-Wilson, A. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015074 · Cited by 202 · see citing works
Self-citation
Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure
Dickstein, K., Chang, P., Willenheimer, R. B., Haunsø, S., Remes, J., Hall, C., & KJEKSHUS, J. K. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)80020-h · Cited by 193 · see citing works
Coronary artery bypass grafting in patients with poor ventricular function
Christakis, G. T., Weisel, R. D., Fremes, S. E., Ivanov, J., David, T. E., Goldman, B. S., & Salerno, T. A. (1992) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)34872-x · Cited by 191 · see citing works
Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison
Poole‐Wilson, P. A. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0839 · Cited by 188 · see citing works
Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation.
Louie, H. W., Laks, H., Milgalter, E., Drinkwater, D. C., Hamilton, M. A., Rc, B., & Stevenson, L. W. (1991) · PubMed · Cited by 169 · see citing works
Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction
Rogers, W. J., Johnstone, D. E., Yusuf, S., Weiner, D. H., Gallagher, P. N., Bittner, V., Ahn, S. A., SCHRON, E. B., Shumaker, S. A., & Sheffield, L. T. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90426-x · Cited by 158 · see citing works
Prevalence, aetiology and management of heart failure in general practice.
Mair, F. S., Crowley, T. S., & Bundred, P. E. (1996) · PubMed Central · Cited by 156 · see citing works
Prevalence of heart failure in three general practices in north west London.
Parameshwar, J. K., Shackell, M. M., Richardson, A., Poole-Wilson, P. A., & Sutton, G. C. (1992) · PubMed Central · Cited by 148 · see citing works
Self-citation
Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993.
Reitsma, J. B., Mosterd, A., de Craen, A. J. M., Koster, R. W., van Capelle, F. J. L., Grobbee, D. E., & Tijssen, J. G. P. (1996) · Heart · doi:10.1136/hrt.76.5.388 · Cited by 138 · see citing works
Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995
Brown, A. M. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0859 · Cited by 134 · see citing works
Does Digoxin Provide Additional Hemodynamic and Autonomic Benefit at Higher Doses in Patients With Mild to Moderate Heart Failure and Normal Sinus Rhythm?
Slatton, M. L., Irani, W. N., HALL, S. A., Marcoux, L., Page, R. L., Grayburn, P. A., & Eichhorn, E. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00057-0 · Cited by 133 · see citing works
The Effect of Beta Adrenergic Blockade on Patterns of Urinary Sodium Excretion
Epstein, S. E., & D, E. B. M. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-65-1-20 · Cited by 126 · see citing works
Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals
Philbin, E. F., Andreou, C., Rocco, T. A., Lynch, L. J., & Baker, S. L. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89177-1 · Cited by 125 · see citing works
Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure
Giles, T. D., Katz, R. J., Sullivan, J. M., Wolfson, P., Haugland, M., Kirlin, P. C., Powers, E. R., Rich, S., Hackshaw, B. T., Chiaramida, A. J., et al. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90294-5 · Cited by 124 · see citing works
Withdrawal of long term diuretic medication in elderly patients: a double blind randomised trial
Walma, E., van Dooren, C., Prins, A., van der Does, E., & Hoes, A. W. (1997) · BMJ · doi:10.1136/bmj.315.7106.464 · Cited by 116 · see citing works
National Trends in the Initial Hospitalization for Heart Failure
Croft, J. B., Giles, W. H., Pollard, R. A., Casper, M. L., Anda, R. F., & Livengood, J. R. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb00939.x · Cited by 114 · see citing works
Comparative Effects of Losartan and Enalapril on Exercise Capacity and Clinical Status in Patients With Heart Failure fn1fn1This study was supported by a grant from Merck Research Laboratories, West Point, Pennsylvania.
Lang, R. M., Elkayam, U., Yellen, L. G., Krauss, D. J., McKelvie, R. S., Vaughan, D. E., Ney, D. E., Makris, L., & Chang, P. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00253-2 · Cited by 112 · see citing works
Beta-blocking agents in heart failure Should they be used and how?
Cleland, J. G. F., Bristow, M. R., Erdmann, E., Remme, W. J., Swedberg, K. B., & Waagstein, F. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014745 · Cited by 101 · see citing works
Self-citation
Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy
Grinstead, W. C., Francis, M. J., Marks, G. F., Tawa, C. B., Zoghbi, W. A., & Young, J. B. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90815-x · Cited by 96 · see citing works
What is the ideal study design for evaluation of treatment for heart failure?: Insights from trials assessing the effect of ACE inhibitors on exercise capacity
Narang, R., Swedberg, K. B., & Cleland, J. G. F. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014670 · Cited by 92 · see citing works
Self-citation
Cardiac Event Rates After Acute Myocardial Infarction in Patients Treated With Verapamil and Trandolapril Versus Trandolapril Alone
HANSEN, J. F., Hagerup, L. M., Sigurd, B. M., Pedersen, F., Mellemgaard, K., Pedersen-Bjergaard, O., & Mortensen, L. S. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00860-0 · Cited by 91 · see citing works
Oral Torsemide in Patients With Chronic Congestive Heart Failure: Effects on Body Weight, Edema, and Electrolyte Excretion
Patterson, J. H., Adams, K. F., Applefeld, M. M., Corder, C. N., Mâsse, B. R., & The Torsemide Investigators Group (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02848.x · Cited by 88 · see citing works
Diltiazem Improves Cardiac Function and Exercise Capacity in Patients With Idiopathic Dilated Cardiomyopathy
Figulla, H. R., Gietzen, F. H., Zeymer, U., Raiber, M., Hegselmann, J., Soballa, R., & Hilgers, R. (1996) · Circulation · doi:10.1161/01.cir.94.3.346 · Cited by 86 · see citing works
SYMPTOMATIC ASSESSMENT OF PATIENTS WITH HEART FAILURE: DOUBLE-BLIND COMPARISON OF INCREASING DOSES OF DIURETICS AND CAPTOPRIL IN MODERATE HEART FAILURE
Cowley, A. J., Wynne, R. D., Stainer, K., Rowley, J. M., & Hampton, J. R. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90298-9 · Cited by 82 · see citing works
Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): Baseline characteristics, prognosis and response to therapy in the vasodilator in heart failure trials (V-HeFT)
Carson, P. E., Johnson, G. R., Fletcher, R. D., & Cohn, J. N. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00503-x · Cited by 81 · see citing works
Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison The NETWORK investigators
Poole-Wilson, P. A. (1998) · Cited by 77 · see citing works
Self-citation
Effects of enalapril on long-term mortality in severe congestive heart failure
Kjekshus, J., Swedberg, K., & Snapinn, S. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90683-p · Cited by 76 · see citing works
Self-citation
Predicting survival after coronary revascularization for ischemic cardiomyopathy
Langenburg, S. E., Buchanan, S. A., Blackbourne, L. H., Scheri, R. P., Sinclair, K. N., Martinez, J., Spotnitz, W. D., Tribble, C. G., & Kron, I. L. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00755-a · Cited by 75 · see citing works
Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Torsemide Investigators Group.
Patterson, J. H., Adams, K. F., Applefeld, M. M., Corder, C. N., & Mâsse, B. R. (1994) · PubMed · Cited by 67 · see citing works
Anticoagulant and antiplatelet therapy in heart failure
Cleland, J. G. F. (1997) · Current Opinion in Cardiology · doi:10.1097/00001573-199705000-00009 · Cited by 67 · see citing works
Self-citation
Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy, and for permanent replacement
Loebe, M. M., HENNIG, E., Müller, J. W., Spiegelsberger, S., Weng, Y., & Hetzer, R. (1997) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(97)01185-8 · Cited by 67 · see citing works
Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
Tsuyuki, R. T., Yusuf, S., Rouleau, J. L., Maggioni, A. P., McKelvie, R. S., Wiecek, E. M., Wang, Y., Pogue, J., Teo, K. K., White, M., et al. (1997) · PubMed · Cited by 63 · see citing works
Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure
Pacher, R., Stanek, B., Globits, S., Berger, R., Hülsmann, M., Frey, B., Schuller, M., Hartter, E., & Ogris, E. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015040 · Cited by 63 · see citing works
The role of calcium antagonists in the treatment of chronic heart failure
Parameshwar, J. K., & Poole-Wilson, P. A. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.suppl_a.38 · Cited by 47 · see citing works
Self-citation
Renal response to candoxatrilat in patients with heart failure
Good, J. M., Peters, A. M., Wilkins, M. R., Jackson, N. C., Oakley, C. M., & Cleland, J. G. F. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00561-4 · Cited by 44 · see citing works
Self-citation
Quality of life on treatment with Metoprolol in Dilated Cardiomyopathy: Results from the MDC trial
Wiklund, I. E., Waagstein, F., Swedberg, K. B., & Hjalmarsson, Å. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf02627961 · Cited by 43 · see citing works
Self-citation
Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction.
GUNDERSEN, T. (1983) · Heart · doi:10.1136/hrt.50.2.135 · Cited by 36 · see citing works
Difference in mortality between patients treated with captopril or enalapril in the xamoterol in severe heart failure study
Pouleur, H. G., Rousseau, M. F., Oakley, C. M., & Rydén, L. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90713-u · Cited by 34 · see citing works
ACE inhibitors for myocardial infarction: how should they be used?
Cleland, J. G. F. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060879 · Cited by 33 · see citing works
Self-citation
Successful mechanical circulatory support for more than two years with a left ventricular assist device in a patient with dilated cardiomyopathy.
Loebe, M. M., Weng, Y., Müller, J., Dandel, M., Halfmann, R., Spiegelsberger, S., & Hetzer, R. (1997) · PubMed · Cited by 33 · see citing works
Effects of nisoldipine therapy on myocardial perfusion and neuro-hormonal status in patients with severe ischaemic left ventricular dysfunction
Rousseau, M., MELIN, J., BENEDICT, C. R., AHN, S., Raphaël, D. A., Bornemann, M., & Pouleur, H. G. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060616 · Cited by 32 · see citing works
ACE inhibitors for the prevention and treatment of heart failure: why are they 'under-used'?
Cleland, J. G. F. (1995) · PubMed · Cited by 31 · see citing works
Self-citation
Captopril in mild heart failure: preliminary observations of a long-term, double-blind, placebo-controlled multicentre trial.
Magnani, B., & Magelli, C. (1986) · PubMed · Cited by 30 · see citing works
Design of the cardiac insufficiency bisoprolol study II (OBIS II)
The CIBIS II Scientific Committee (1997) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1997.tb00181.x · Cited by 30 · see citing works
Changing patterns of investigation and treatment of cardiac failure in hospital.
Hillis, G. S., Al‐Mohammad, A., Wood, M., & Jennings, K. (1996) · Heart · doi:10.1136/hrt.76.5.427 · Cited by 29 · see citing works
Severity of heart failure and dosage of angiotensin converting enzyme inhibitors
Clark, A. L., & Coats, A. J. S. (1995) · BMJ · doi:10.1136/bmj.310.6985.973 · Cited by 28 · see citing works
Patient Characteristics in Cases of Chronic Severe Heart Failure with Different Degrees of Left Ventricular Systolic Dysfunction
Eriksson, S. V., KJEKSHUS, J. K., Offstad, J. T., & Swedberg, K. B. (2008) · Cardiology · doi:10.1159/000176668 · Cited by 27 · see citing works
Self-citation
Screening For Left Ventricular Dysfunction and Chronic Heart Failure
Cleland, J. G. F. (1997) · Disease Management & Health Outcomes · doi:10.2165/00115677-199701040-00001 · Cited by 24 · see citing works
Self-citation
Development of congestive heart failure after treatment with metoprolol in acute myocardial infarction.
Herlitz, J. D., Hjalmarson, Å. C., Holmberg, S., Swedberg, K. B., VEDIN, A., Waagstein, F., Waldenström, A. P., Wedel, H., Wilhelmsen, L., & Wilhelmsson, C. (1984) · Heart · doi:10.1136/hrt.51.5.539 · Cited by 22 · see citing works
Self-citation
Measurement of the quality of life in congestive heart failure—Influence of drug therapy
Bulpitt, C. J., & FLETCHER, A. E. (1988) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00633423 · Cited by 21 · see citing works
How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?
Cleland, J. G. F., & Puri, S. (1994) · Heart · doi:10.1136/hrt.72.3_suppl.s81 · Cited by 21 · see citing works
Self-citation
A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure
Andrews, R. V., Charlesworth, A., Evans, A. J., & Cowley, A. J. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015351 · Cited by 16 · see citing works
Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study
Schofer, J., HOBUSS, M., Aschenberg, W., & Tews, A.-M. (1990) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059786 · Cited by 14 · see citing works
Angiography and the aetiology of heart failure
Brookes, C. I. O., Hart, P., Keogh, B. E., & Cleland, J. G. F. (1995) · Postgraduate Medical Journal · doi:10.1136/pgmj.71.838.480 · Cited by 12 · see citing works
Self-citation
Amlodipine in Chronic Heart Failure
Bobbio, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361413 · Cited by 8 · see citing works
Prognosis of heart failure — a population-based study of the outcome in incident cases
Cowie, M., Suresh, V., Wood, D. A., Coats, A. J. S., Thompson, S. G., Poole-Wilson, P. A., & Sutton, G. C. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)81587-8 · Cited by 7 · see citing works
Self-citation
Influence of Aetiology on the Effects of Treatment in Heart Failure
Cleland, J. G. F., & Swedberg, K. B. (1999) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748739900600302 · Cited by 6 · see citing works
Self-citation
Prognosis of Heart Failure - A Population-based Study of the Outcome in Incident Cases
Cowie, M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)84653-0 · Cited by 5 · see citing works
Dofetilide: A New Class III Antiarrhythmic Drug Which Is Safe in Patients With Congestive Heart Failure
Torp-Pedersen, C. T. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)84407-5 · Cited by 3 · see citing works
High- versus low-dose ACE-inhibition in patients with chronic heart failure: A placebo-controlled study with imidapril
vanVeldhuisen, D., GenthZoth, S., Netzer, T., & Brouwer, J. (1997) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1 · see citing works

Flagged first, then by citations

3 of the 111 references couldn’t be matched to a known paper.

Sorted by citations

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214 · see citing works
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
Cazeau, S., Leclercq, C., Lavergne, T., Walker, S., Varma, C., Linde, C. M., Garrigue, S., KAPPENBERGER, L. J., Haywood, G. A., Santini, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441202 · Cited by 2,718 · see citing works
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
Troughton, R. W., FRAMPTON, C. M. A., Yandle, T. G., Espine, E. A., Nicholls, M. G., & Richards, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02060-2 · Cited by 1,355 · see citing works
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca <sup>2+</sup> -ATPase in Patients With Advanced Heart Failure
Jessup, M., Greenberg, B., Mancini, D., Cappola, T., Pauly, D. F., Jaski, B., Yaroshinsky, A., Zsebo, K. M., Dittrich, H., & Hajjar, R. J. (2011) · Circulation · doi:10.1161/circulationaha.111.022889 · Cited by 760 · see citing works
Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block
Nelson, G. S., Berger, R. D., Fetics, B. J., Talbot, M. W., Spinelli, J., Hare, J. M., & Kass, D. A. (2000) · Circulation · doi:10.1161/01.cir.102.25.3053 · Cited by 759 · see citing works
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey
Cleland, J. G. F., Solal, A. C., Aguilar, J. A. C., Dietz, R., Eastaugh, J., Folláth, F., Freemantle, N., Gavazzi, A., van Gilst, W. H., Hobbs, R. F., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11601-1 · Cited by 535 · see citing works
Self-citation
Cardiovascular prevention and blood pressure reduction
Staessen, J. A., Wang, J., & Thijs, L. (2003) · Journal of Hypertension · doi:10.1097/00004872-200306000-00002 · Cited by 482 · see citing works
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical Trial
Jaski, B. E., Jessup, M. L., Mancini, D. M., Cappola, T. P., Pauly, D. F., Greenberg, B., Borow, K., Dittrich, H., Zsebo, K. M., & Hajjar, R. J. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.01.013 · Cited by 457 · see citing works
The relationship between cholesterol and survival in patients with chronic heart failure
Rauchhaus, M., Clark, A. L., Doehner, W., Davos, C. H., Bolger, A. P., Sharma, R. K., Coats, A. J. S., & Anker, S. D. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.016 · Cited by 444 · see citing works
Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey
Lenzen, M. J. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.006 · Cited by 369 · see citing works
The heart failure epidemic: exactly how big is it?
Cleland, J. G. F. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2493 · Cited by 331 · see citing works
Self-citation
Persistently Increased Serum Concentrations of Cardiac Troponin T in Patients With Idiopathic Dilated Cardiomyopathy Are Predictive of Adverse Outcomes
Sato, Y., Yamada, T., Taniguchi, R., Nagai, K., Makiyama, T., Okada, H., Kataoka, K., Ito, H., Matsumori, A., Sasayama, S., et al. (2001) · Circulation · doi:10.1161/01.cir.103.3.369 · Cited by 308 · see citing works
The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure
Witte, K. K., Nikitin, N. P., Parker, A. C., von Haehling, S., Volk, H., Anker, S. D., Clark, A. L., & Cleland, J. G. F. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi442 · Cited by 298 · see citing works
Self-citation
The Crucial Role of Patient Education in Heart Failure
Strömberg, A. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.002 · Cited by 265 · see citing works
Perindopril for Elderly People with Chronic Heart Failure: The PEP-CHF Study
Cleland, J. G. F., Tendera, M., Adamus, J., Freemantle, N., Gray, C. S., Lye, M., O’Mahony, D., Poloński, L., & Taylor, J. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00039-2 · Cited by 254 · see citing works
Self-citation
Blood Pressure Reduction and Cardiovascular Prevention: An Update Including the 2003-2004 Secondary Prevention Trials
Staessen, J. A., Li, Y., Thijs, L., & Wang, J. (2005) · Hypertension Research · doi:10.1291/hypres.28.385 · Cited by 245 · see citing works
Is the Prognosis of Heart Failure Improving?
Cleland, J. G. F., Gemmell, I., Khand, A. U., & Boddy, A. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00032-x · Cited by 243 · see citing works
Self-citation
Chronic heart failure and micronutrients
Witte, K. K., Clark, A. L., & Cleland, J. G. F. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01227-x · Cited by 237 · see citing works
Self-citation
Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation
Molhoek, S. G., Bax, J. J., Bleeker, G. B., Boersma, E. H., van Erven, L., Paul Steendijk, A., van der Wall, E. E., & Schalij, M. J. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.08.028 · Cited by 209 · see citing works
Diastolic heart failure: neglected or misdiagnosed?
Banerjee, P., Banerjee, T., Khand, A. U., Clark, A. L., & Cleland, J. G. F. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01704-1 · Cited by 180 · see citing works
Self-citation
Angiotensin-converting enzyme I inhibitory activity of phlorotannins from Ecklonia stolonifera
Jung, H. A., Hyun, S. K., Kim, H. R., & Choi, J. S. (2006) · Fisheries Science · doi:10.1111/j.1444-2906.2006.01288.x · Cited by 175 · see citing works
Estrogenic hormone action in the heart: regulatory network and function
Babiker, F. A. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00526-0 · Cited by 171 · see citing works
The Euro Heart Failure Survey of The EUROHEART Survey Programme: A Survey on the Quality of Care Among Patients with Heart Failure in Europe
Cleland, J. G. F., Swedberg, K. B., Solal, A. C., Cosín‐Aguilar, J., Dietz, R., Folláth, F., Gavazzi, A., Hobbs, R. F., Korewicki, J., Madeira, H. C., et al. (2000) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00081-7 · Cited by 153 · see citing works
Self-citation
β-ADRENERGIC RECEPTORS AND RECEPTOR SIGNALING IN HEART FAILURE
Post, S. R., Hammond, H. K., & Insel, P. A. (1999) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.343 · Cited by 153 · see citing works
Management of heart failure among very old persons living in long-term care: Has the voice of trials spread?
Gambassi, G., Forman, D. E., Lapane, K. L., Mor, V., Sgadari, A., Lipsitz, L. A., & Bernabei, R. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90313-2 · Cited by 121 · see citing works
Which patients with heart failure respond best to multidisciplinary disease management?
Riegel, B. J., Carlson, B., Glaser, D. N., & Hoagland, P. M. (2000) · Journal of Cardiac Failure · doi:10.1054/jcaf.2000.19226 · Cited by 113 · see citing works
Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure
Goto, T., Takase, H., Toriyama, T., Sugiura, T., Sato, K., Ueda, R., & Dohi, Y. (2003) · Heart · doi:10.1136/heart.89.11.1303 · Cited by 110 · see citing works
The evidence for beta blockers in heart failure
Cleland, J. G. F., McGowan, J., Clark, A. L., & Freemantle, N. (1999) · BMJ · doi:10.1136/bmj.318.7187.824 · Cited by 107 · see citing works
Self-citation
Effects of Angiotensin-Converting Enzyme Inhibitors and Digoxin on Health Outcomes of Very Old Patients With Heart Failure
Gambassi, G. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.1.53 · Cited by 103 · see citing works
Antioxidative and ACE inhibitory activities of protein hydrolysates from the muscle of brownstripe red snapper prepared using pyloric caeca and commercial proteases
Khantaphant, S., Benjakul, S., & Kishimura, H. (2010) · Process Biochemistry · doi:10.1016/j.procbio.2010.09.005 · Cited by 102 · see citing works
Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial
Hutcheon, S., Gillespie, N. D., Crombie, I. K., Struthers, A. D., & McMurdo, M. E. T. (2002) · Heart · doi:10.1136/heart.88.4.373 · Cited by 101 · see citing works
Elimination of Early Rehospitalization in a Randomized, Controlled Trial of Multidisciplinary Care in a High-Risk, Elderly Heart Failure Population: The Potential Contributions of Specialist Care, Clinical Stability and Optimal Angiotensin-Converting Enzyme Inhibitor Dose at Discharge
McDonald, K., Ledwidge, M. T., Cahill, J., Kelly, J., Quigley, P. J., MAURER, B. J., Begley, F., Ryder, M., Travers, B., Timmons, L., et al. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00134-3 · Cited by 95 · see citing works
Sudden Death in Heart Failure: Vascular or Electrical?
Cleland, J. G. F., Massie, B. M., & Packer, M. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00009-4 · Cited by 92 · see citing works
Self-citation
Continous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure
Braunschweig, F. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2690 · Cited by 87 · see citing works
Coenzyme Q10: is there a clinical role and a case for measurement?
Molyneux, S. L., Young, J. M., Florkowski, C. M., Lever, M., & George, P. M. (2008) · PubMed Central · Cited by 87 · see citing works
Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure
Bettencourt, P., Friões, F., Azevedo, A., Dias, P., Pimenta, J. M., Rocha‐Gonçalves, F., & Ferreira, A. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(03)00115-3 · Cited by 84 · see citing works
An ethnographic approach to understanding the illness experiences of patients with congestive heart failure and their family members
Mahoney, J. S. (2001) · Heart & Lung · doi:10.1067/mhl.2001.119832 · Cited by 78 · see citing works
Heart-type fatty acid-binding protein in cardiovascular disease: A systemic review
Otaki, Y., Watanabe, T., & Kubota, I. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.09.007 · Cited by 67 · see citing works
Prioritizing symptom management in the treatment of chronic heart failure
Koshy, A. O., Gallivan, E. R., McGinlay, M., Straw, S., Drozd, M., Toms, A. G., Gierula, J., Cubbon, R. M., Kearney, M. T., & Witte, K. K. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12875 · Cited by 66 · see citing works
Persistently Increased Serum Concentration of Heart-Type Fatty Acid-Binding Protein Predicts Adverse Clinical Outcomes in Patients With Chronic Heart Failure
Niizeki, T., Takeishi, Y., Arimoto, T., Nozaki, N., Hirono, O., Watanabe, T., Nitobe, J., Miyashita, T., Miyamoto, T., Koyama, Y., et al. (2007) · Circulation Journal · doi:10.1253/circj.72.109 · Cited by 66 · see citing works
The Role of Estrogen in Cardiac Metabolism and Diastolic Function
Li, S., & Gupte, A. A. (2017) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-13-1-4 · Cited by 65 · see citing works
Circulating Levels of Myocardial Proteins Predict Future Deterioration of Congestive Heart Failure
Sugiura, T., Takase, H., Toriyama, T., Goto, T., Ueda, R., & Dohi, Y. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.04.025 · Cited by 65 · see citing works
Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study
Cleland, J. G. F. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2570 · Cited by 60 · see citing works
Self-citation
Inhibitory Activities of Cassia tora and its Anthraquinone Constituents on Angiotensin‐Converting Enzyme
Hyun, S. K., Lee, H., Kang, S. S., Chung, H. Y., & Choi, J. S. (2008) · Phytotherapy Research · doi:10.1002/ptr.2579 · Cited by 59 · see citing works
Has the survival of the heart failure population changed? lessons from trials
Cleland, J. G. F., & Clark, A. L. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)01011-x · Cited by 52 · see citing works
Self-citation
Atrial Fibrillation Burden During the Post‐Implant Period After CRT Using Device‐Based Diagnostics
Hügl, B. J., BRUNS, H., UNTERBERG‐BUCHWALD, C., Große, A., Stegemann, B., Lauer, B., Geller, J. C., & Gasparini, M. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00482.x · Cited by 49 · see citing works
Risk of cardiovascular death in elderly patients with possible heart failure
Alehagen, U., Lindstedt, G., Levin, L., & Dahlström, U. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.10.006 · Cited by 47 · see citing works
Outcome Studies with Device Therapy in Patients with Heart Failure
Cleland, J. G. F., Thackray, S. D. R., GOODGE, L., Kaye, G., & Cooklin, M. (2002) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2002.tb01958.x · Cited by 47 · see citing works
Self-citation
Long‐Term Follow‐Up of Cardiac Resynchronization Therapy in Patients with End‐Stage Heart Failure
Molhoek, S. G., Bax, J. J., Bleeker, G. B., Holman, E. R., ERVEN, L. V., Bootsma, M., Boersma, E. H., Paul Steendijk, A., van der Wall, E. E., & Schalij, M. J. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.40685.x · Cited by 46 · see citing works
Increasing Awareness and Improving the Management of Heart Failure in Europe: The IMPROVEMENT of HF Initiative
The Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00021-5 · Cited by 43 · see citing works
Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives
Witte, K. K., & Clark, A. L. (2006) · Heart Failure Reviews · doi:10.1007/s10741-006-9194-4 · Cited by 42 · see citing works
Identification and characterization of hydroxymethylbilane synthase mutations causing acute intermittent porphyria: Evidence for an ancestral founder of the common G111R mutation
Siervi, A. D., Rossetti, M. V., Parera, V. E., Astrin, K. H., Aizencang, G. I., Glass, I. A., Batlle, A. M. D. C., & Desnick, R. J. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991008)86:4 · Cited by 42 · see citing works
Experiences of a community pharmacy service to support adherence and self-management in chronic heart failure
Lowrie, R., Johansson, L., Forsyth, P., Bryce, S. L., McKellar, S., & Fitzgerald, N. (2013) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-013-9889-2 · Cited by 41 · see citing works
Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)
Baruch, L., Glazer, R. D., Aknay, N., Vanhaecke, J., Heywood, J. T., Anand, I. S., Krum, H., Hester, A., & Cohn, J. N. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.06.001 · Cited by 39 · see citing works
Recent advances in cardiac hypertrophy.
Olivetti, G., Cigola, E., Maestri, R., Lagrasta, C., Corradi, D., & Quaini, F. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00298-9 · Cited by 43 · see citing works
Trends and predictors of hospitalization, readmissions and length of stay in ambulatory patients with heart failure
Capell, E. F., Colet, J. C., Miralles, J. D., Gich, I. J., Wensing, M., & Verdú-Rotellar, J. M. (2012) · Revista Clínica Española · doi:10.1016/j.rce.2012.10.006 · Cited by 38 · see citing works
Cholesterol — A marker of nutritional status in mild to moderate heart failure
Araújo, J. P., Friões, F., Azevedo, A., Lourenço, P., Rocha‐Gonçalves, F., Ferreira, A., & Bettencourt, P. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.05.026 · Cited by 38 · see citing works
Endothelin antagonists for chronic heart failure: do they have a role?
Cowburn, P. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2557 · Cited by 38 · see citing works
Aetiology, Comorbidity and Drug Therapy of Chronic Heart Failure in the Real World: The EPICA Substudy
Ceia, F., Fonseca, C., Mota, T., Morais, H., Matias, F., Costa, C., & Oliveira, A. G. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.09.003 · Cited by 37 · see citing works
Therapeutic potential of cyclic nucleotide phosphodiesterase inhibitors in heart failure
Movsesian, M. A. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.5.963 · Cited by 37 · see citing works
Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium
Karlsson, J., Brurok, H., Eriksen, M., Towart, R., Toft, K. G., Moen, O., Engebretsen, B. J., Jynge, P., & Refsum, H. (2001) · Acta Radiologica · doi:10.1034/j.1600-0455.2001.420602.x · Cited by 30 · see citing works
Estudio europeo del tratamiento ambulatorio de la insuficiencia cardíaca realizado por cardiólogos
Salvador, M. J., Sebaoun, A., Sonntag, F., Blanch, P., Silber, S., Aznar, J., & Michel Komajda, N. (2004) · Revista Española de Cardiología · doi:10.1016/s0300-8932(04)77259-0 · Cited by 26 · see citing works
Coenzyme Q10; an adjunctive therapy for congestive heart failure?
Molyneux, S. L., Florkowski, C. M., Richards, M., Lever, M., Young, J. M., & George, P. M. (2009) · PubMed · Cited by 24 · see citing works
Atriobiventricular pacing improves exercise capacity in patients with heart failure and intraventricular conduction delay
Varma, C., Sharma, S., Firoozi, S., McKenna, W. J., & Daubert, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02849-8 · Cited by 22 · see citing works
What is the optimal medical management of ischemic heart failure?
Cleland, J. G. F., Alamgir, F. M., Nikitin, N. P., Clark, A. L., & Norell, M. S. (2001) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2001.20670 · Cited by 22 · see citing works
Self-citation
Discharge treatment with angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction
Vicent, L., Juan Cinca, A., Vázquez, R., González‐Juanatey, J. R., Rivera, M., Segovia, J., Pascual-Figal, D. A., Bover, R., Worner, F., Delgado, J. F., et al. (2019) · Internal Medicine Journal · doi:10.1111/imj.14289 · Cited by 21 · see citing works
A community model of group rehabilitation for older patients with chronic heart failure: A pilot study
Hui, E., Yang, H. M., Chan, L. S., Or, K. H., Lee, D., Yu, C., & Woo, J. (2006) · Disability and Rehabilitation · doi:10.1080/09638280600646219 · Cited by 21 · see citing works
A survey of outpatient management of elderly heart failure patients in Poland—treatment patterns
Rywik, T. M., Rywik, S. L., Korewicki, J., Broda, G., Sarnecka, A., & Drewla, J. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.04.027 · Cited by 21 · see citing works
Cardiac resynchronization: a cornerstone in the foundation of device therapy for heart failure**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
Saxon, L. A., & Marco, T. D. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01638-2 · Cited by 21 · see citing works
Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches
Koniari, K., Parissis, J., PARASKEVAIDIS, I. A., & ANASTASIOU‐NANA, M. I. (2012) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872612457044 · Cited by 20 · see citing works
Diuretic Therapy in Elderly Heart Failure Patients With and Without Left Ventricular Systolic Dysfunction
Kraaij, D. J. W. V., Jansen, R. W. M. M., Gribnau, F. W. J., & Hoefnagels, W. H. L. (2000) · Drugs & Aging · doi:10.2165/00002512-200016040-00005 · Cited by 20 · see citing works
Inappropriate use of loop diuretics in elderly patients
Kelly, J. (2000) · Age and Ageing · doi:10.1093/ageing/29.6.489 · Cited by 20 · see citing works
The Cardiac Insufficiency Bisoprolol Study II
Poole-Wilson, P. A. (1999) · The Lancet · doi:10.1016/s0140-6736(05)74354-3 · Cited by 20 · see citing works
Self-citation
Contemporary management of heart failure in clinical practice
Cleland, J. G. F. (2002) · Heart · doi:10.1136/heart.88.suppl_2.ii5 · Cited by 19 · see citing works
Self-citation
Review. The electrocardiogram in heart failure
Kelly, J. (2000) · Age and Ageing · doi:10.1093/ageing/29.3.203 · Cited by 19 · see citing works
European Study of Ambulatory Management of Heart Failure by Cardiologists
Salvador, M. J., Sebaoun, A., Sonntag, F., Blanch, P., Silber, S., Aznar, J., & Michel Komajda, N. (2004) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60209-0 · Cited by 19 · see citing works
The risk of cardiovascular death in elderly patients with possible heart failure. Results from a 6-year follow-up of a Swedish primary care population
Alehagen, U., Lindstedt, G., Levin, L., & Dahlström, U. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.03.031 · Cited by 18 · see citing works
RESICARD: East Paris network for the management of heart failure: Absence of effect on mortality and rehospitalization in patients with severe heart failure admitted following severe decompensation
Assyag, P., Renaud, T., Solal, A. C., Viaud, M., Krys, H., Bundalo, A., Michel, P.-L., Boukobza, R., Bourgueil, Y., & Cohen, A. A. (2009) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2008.10.013 · Cited by 17 · see citing works
Carvedilol for Heart Failure: Clinical Trials in Progress
McGowan, J., Murphy, R. L. W., & Cleland, J. G. F. (1999) · Heart Failure Reviews · doi:10.1023/a:1009812019524 · Cited by 16 · see citing works
Self-citation
Implantable cardioverter defibrillators for prevention of sudden cardiac Death
Sukhija, R., Mehta, V., Leonardi, M., & Mehta, J. L. (2007) · Clinical Cardiology · doi:10.1002/clc.20001 · Cited by 14 · see citing works
ICD lead implantation via persistent left superior vena cava
Yasuda, M., Nakazato, Y., & Daida, H. (2003) · Heart · doi:10.1136/heart.89.11.1307 · Cited by 11 · see citing works
Carvedilol: something else than a simple betablocker?
Palazzuoli, A., Calabria, P., Verzuri, M. S., & Auteri, A. (2002) · PubMed · Cited by 11 · see citing works
Effect of nolomirole on monocrotaline-induced heart failure
Pasini, E., Anna, C., Pastore, F., Razzetti, R., Bongrani, S., Luca, G. G., & Ferrari, R. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00246-9 · Cited by 11 · see citing works
Angiotensin converting enzyme inhibitory benzopyranoids from Angelica gigas
Hyun, S. K., Oh, Y. N., Kwon, H. J., & Kim, B. W. (2013) · Food Science and Biotechnology · doi:10.1007/s10068-013-0275-6 · Cited by 10 · see citing works
Fish oils – adjuvant therapy in chronic heart failure?
Witte, K. K., & Clark, A. L. (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000136728.27524.f5 · Cited by 10 · see citing works
Digitalis inhibits and furosemide does not change the in vitro phagocytic function of neutrophils of healthy subjects
Muniz‐Junqueira, M. I. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00142-5 · Cited by 10 · see citing works
Heart Failure Management Programmes: Delivering the Message
Dickstein, K., & Jaarsma, T. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.006 · Cited by 9 · see citing works
What is the optimal medical management of ischaemic heart failure?
Cleland, J. G. F., John, J., Dhawan, J., & Clark, A. L. (2001) · British Medical Bulletin · doi:10.1093/bmb/59.1.135 · Cited by 9 · see citing works
Self-citation
Impact of Different Pacing Modes on Left Ventricular Contractility Following Cardiopulmonary Bypass
Bakhtiary, F., DOGAN, S., Dzemali, O., Ackermann, H., Kleine, P., Schächinger, V., Moritz, A., & Aybek, T. (2007) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00817.x · Cited by 9 · see citing works
Neurohormones and heart failure
Mendzef, S. D., & Slovinski, J. R. (2004) · Nursing Clinics of North America · doi:10.1016/j.cnur.2004.07.004 · Cited by 8 · see citing works
Angiotensin-converting enzyme inhibitory activity of Senna garrettiana active compounds: Potential markers for standardized herbal medicines
Charoonratana, T., & Madaka, F. (2018) · Pharmacognosy Magazine · doi:10.4103/pm.pm_325_17 · Cited by 8 · see citing works
Reduction in hospitalization rates following cardiac resynchronisation therapy in cardiac failure: experience from a single centre
Dixon, L., Murtagh, J., RICHARDSON, S., & Chew, E. W. (2004) · EP Europace · doi:10.1016/j.eupc.2004.08.006 · Cited by 8 · see citing works
Pharmacological options for acute heart failure syndromes: current treatments and unmet needs
Nieminen, M. S. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui009 · Cited by 7 · see citing works
Is echocardiography a valid tool to screen for left ventricular systolic dysfunction in chronic survivors of acute myocardial infarction? A comparison with radionuclide ventriculography
Galasko, G. I. W., Basu, S., Lahiri, A., & Senior, R. (2004) · Heart · doi:10.1136/hrt.2003.027425 · Cited by 7 · see citing works
Can new pulmonary gas exchange parameters contribute to evaluation of pulmonary congestion in left-sided heart failure?
Moesgaard, J., Kristensen, J. H., Malczynski, J., Holst‐Hansen, C., Rees, S. E., Murley, D., Andreassen, S., Frøkjær, J. B., & Toft, E. S. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70042-x · Cited by 5 · see citing works
Prescription in patients with chronic heart failure and multimorbidity attended in primary care.
Capell, E. F., Verdú-Rotellar, J. M., Colet, J. C., Miralles, J. D., Hermosilla, E., Wensing, M., & Suñol, R. (2013) · PubMed · Cited by 5 · see citing works
Natriuretic peptides for heart failure screening in nursing homes: a systematic review
Homar, V., Miroševič, Š., Švab, I., & Lainščak, M. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09944-w · Cited by 5 · see citing works
Treatment Of Heart Failure In A Teaching Hospital In Ghana, West Africa
(2007) · The Internet Journal of Third World Medicine · doi:10.5580/17c2 · Cited by 4 · see citing works
Carvedilol in the treatment of elderly patients with chronic heart failure
Witte, K. K. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1044 · Cited by 4 · see citing works
Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use
Bourgault, C., Elstein, E., Baltzan, M., LeLorier, J., & Suissa, S. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.595 · Cited by 4 · see citing works

New treatments for heart failure and exercise capacity
Solal, A. C., & Beauvais, F. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2374 · Cited by 1 · see citing works
Exercise Tolerance as a Guide to Therapeutic Efficacy for Heart Failure
Cohn, J. N. (1999) · Circulation · doi:10.1161/01.cir.100.22.2208 · Cited by 3 · see citing works
The treatment of heart failure—what next?
Davies, R. L., & Sheridan, D. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb04181.x · Cited by 3 · see citing works
Improving exercise capacity and quality of life using non‐invasive heart failure treatments: evidence from clinical trials
von Haehling, S., Arzt, M. E., Doehner, W., Edelmann, F., Evertz, R., Ebner, N., Herrmann‐Lingen, C., Garfias‐Veitl, T., Koziolek, M. J., Noutsias, M., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1838 · Cited by 116 · see citing works
Exercise Capacity in Chronic Heart Failure
Mentzer, G. G., & Auseon, A. J. (2012) · US Cardiology Review · doi:10.15420/usc.2012.9.1.57 · Cited by 2 · see citing works

Authors: Cleland, J. G., Swedberg, K., & Poole-Wilson, P. A.
Affiliations: University of Glasgow (GB)
Imperial College London (GB)
Corresponding author: Cleland, John GF
ORCID: Cleland, John GF
Swedberg, Karl
Venue: The Lancet
Publisher: Elsevier BV
Published: 1998-08
Volume: 352
Pages: SI19-SI28
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(98)90015-0
OpenAlex: W2075926626
Cited by: 141
References: 111
Citations by year: 2026: 1 · 2025: 2 · 2022: 3 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 3 · 2014: 1 · 2013: 5 · 2012: 2
FWCI: 3.10
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
Keywords: heart failure, heart failure treatment, exercise capacity, hemodynamics, symptom improvement, surrogate endpoints, clinical trial endpoints, drug approval
MeSH terms: Cardiac Output, Low, Clinical Trials as Topic, Humans, Prognosis, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Successes and failures of current treatment of heart failure

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks